Veracyte Inc (VCYT) - Product Pipeline Analysis, 2025 Update

Summary

Veracyte Inc (Veracyte) is a diagnostics company that uses genomic technology to resolve diagnostic ambiguity. the company offers products such as Afirma, Percepta, Envisia, Prosigna, Lymphmark and Decipher. Its products are used in therapeutic areas such as thyroid, prostate, breast, bladder, lung cancers and interstitial lung diseases. Veracyte also provides vitro diagnostics (IVD) services including manufacturing, quality control, assay and process transfer, supply chain and other services to biopharmaceutical and diagnostics companies. The company operates in the US, France and Israel. Veracyte is headquartered in San Francisco, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Veracyte Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company


Veracyte Inc Company Overview
Veracyte Inc Company Snapshot
Veracyte Inc Pipeline Products and Ongoing Clinical Trials Overview
Veracyte Inc – Pipeline Analysis Overview
Veracyte Inc - Key Facts
Veracyte Inc - Major Products and Services
Veracyte Inc Pipeline Products by Development Stage
Veracyte Inc Ongoing Clinical Trials by Trial Status
Veracyte Inc Pipeline Products Overview
Afirma - Risk of Recurrence
Afirma - Risk of Recurrence Product Overview
Afirma - Thyroid Cancer Staging/ Prognosis Test
Afirma - Thyroid Cancer Staging/ Prognosis Test Product Overview
Afirma Xpression Atlas - Pulmonology
Afirma Xpression Atlas - Pulmonology Product Overview
AI Based Liquid Biopsy Assay - Solid Tumors
AI Based Liquid Biopsy Assay - Solid Tumors Product Overview
BronchoGen Test
BronchoGen Test Product Overview
C2inform MRD Test
C2inform MRD Test Product Overview
Comprehensive Genomic Profiling Test
Comprehensive Genomic Profiling Test Product Overview
Decipher Prostate Biopsy Test
Decipher Prostate Biopsy Test Product Overview
Decipher Prostate Biopsy Test Clinical Trial
Decipher Prostate RP Assay
Decipher Prostate RP Assay Product Overview
Diagnostic Assay - Renal Cancer
Diagnostic Assay - Renal Cancer Product Overview
Disease Diagnosis Device
Disease Diagnosis Device Product Overview
Envisia - Disease Progression Test
Envisia - Disease Progression Test Product Overview
Envisia - Rx Response Test
Envisia - Rx Response Test Product Overview
Envisia Genomic Classifier
Envisia Genomic Classifier Product Overview
Envisia IVD Test
Envisia IVD Test Product Overview
MRD Test - Muscle-Invasive Bladder Cancer
MRD Test - Muscle-Invasive Bladder Cancer Product Overview
nCounter Dx LymphMark Assay
nCounter Dx LymphMark Assay Product Overview
nCounter FLEX Analysis System - Idiopathic Pulmonary Fibrosis Test
nCounter FLEX Analysis System - Idiopathic Pulmonary Fibrosis Test Product Overview
Percepta Atlas
Percepta Atlas Product Overview
Percepta Nasal Swab Test
Percepta Nasal Swab Test Product Overview
Percepta Nasal Swab Test Clinical Trial
Prosigna NGS Test
Prosigna NGS Test Product Overview
Veracyte Inc - Key Competitors
Veracyte Inc - Key Employees
Veracyte Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Veracyte Inc, Recent Developments
May 28, 2025: Veracyte Announces Multiple Abstracts To Be Presented at ASCO, Demonstrating Power of Decipher GRID to Advance New Prostate and Bladder Cancer Research
Apr 25, 2025: Veracyte Announces Expanded Availability of Decipher Prostate Test to Patients With Metastatic Prostate Cancer
Apr 22, 2025: Veracyte Announces Multiple Abstracts Demonstrating Power of Decipher Testing To Fuel New Prostate and Bladder Cancer Insights Will Be Presented at Aua Annual Meeting
Apr 21, 2025: Veracyte Announces Decipher Prostate Genomic Classifier Results are Linked to Real-World Data in National Cancer Institute’s SEER Specialized Database Release
Mar 25, 2025: New Data Demonstrate Accuracy of Veracyte’s Whole-Genome Sequencing-Based MRD Testing Platform for Muscle-Invasive Bladder Cancer
Feb 14, 2025: New Data at ASCO GU Show Power of Veracyte’s Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and Bladder Cancer Research
Feb 11, 2025: Veracyte Announces 17 Abstracts Demonstrating Its Decipher Tests’ Leadership in Urologic Cancers To Be Presented at the 2025 Asco GU Symposium
Oct 02, 2024: New Data Presented at ASTRO 2024 Show that Veracyte’s Decipher Prostate Test Predicts Aggressive Prostate Cancer in African American Men
Sep 04, 2024: Veracyte Adds Brent Shafer and Tom Miller to Board of Directors
May 06, 2024: 14 Studies Presented at AUA 2024 Show Decipher Tests’ Ability to Help Personalize Care for Prostate and Bladder Cancer Patients and Advance Disease Understanding
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Veracyte Inc Pipeline Products and Ongoing Clinical Trials Overview
Veracyte Inc Pipeline Products by Equipment Type
Veracyte Inc Pipeline Products by Indication
Veracyte Inc Ongoing Clinical Trials by Trial Status
Veracyte Inc, Key Facts
Veracyte Inc, Major Products and Services
Veracyte Inc Number of Pipeline Products by Development Stage
Veracyte Inc Pipeline Products Summary by Development Stage
Veracyte Inc Ongoing Clinical Trials by Trial Status
Veracyte Inc Ongoing Clinical Trials Summary
Afirma - Risk of Recurrence - Product Status
Afirma - Risk of Recurrence - Product Description
Afirma - Thyroid Cancer Staging/ Prognosis Test - Product Status
Afirma - Thyroid Cancer Staging/ Prognosis Test - Product Description
Afirma Xpression Atlas - Pulmonology - Product Status
Afirma Xpression Atlas - Pulmonology - Product Description
AI Based Liquid Biopsy Assay - Solid Tumors - Product Status
AI Based Liquid Biopsy Assay - Solid Tumors - Product Description
BronchoGen Test - Product Status
BronchoGen Test - Product Description
C2inform MRD Test - Product Status
C2inform MRD Test - Product Description
Comprehensive Genomic Profiling Test - Product Status
Comprehensive Genomic Profiling Test - Product Description
Decipher Prostate Biopsy Test - Product Status
Decipher Prostate Biopsy Test - Product Description
Decipher Prostate Biopsy Test - A Validation Study on the Impact of Decipher Testing on Treatment Recommendations in African-american and Non-african American Men with Prostate Cancer (VANDAAM Study)
Decipher Prostate Biopsy Test - Genomics in Michigan to Adjust Outcomes in Prostate Cancer (G-MAJOR): A Randomized Multi-center Study for Men with Newly Diagnosed Favorable Risk Prostate Cancer
Decipher Prostate Biopsy Test - STAMPEDE: Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy: A Multi-Stage Multi-Arm Randomized Controlled Trial
Decipher Prostate Biopsy Test - SURE-02_An Open Label, Single-arm, Phase 2 Study of Perioperative Pembrolizumab Plus Sacituzumab Govitecan, and Bladder-saving Approach, for Patients With Muscle-invasive Bladder Cancer Who Cannot Receive or Refuse Cisplatin-based Chemotherapy
Decipher Prostate RP Assay - Product Status
Decipher Prostate RP Assay - Product Description
Diagnostic Assay - Renal Cancer - Product Status
Diagnostic Assay - Renal Cancer - Product Description
Disease Diagnosis Device - Product Status
Disease Diagnosis Device - Product Description
Envisia - Disease Progression Test - Product Status
Envisia - Disease Progression Test - Product Description
Envisia - Rx Response Test - Product Status
Envisia - Rx Response Test - Product Description
Envisia Genomic Classifier - Product Status
Envisia Genomic Classifier - Product Description
Envisia IVD Test - Product Status
Envisia IVD Test - Product Description
MRD Test - Muscle-Invasive Bladder Cancer - Product Status
MRD Test - Muscle-Invasive Bladder Cancer - Product Description
nCounter Dx LymphMark Assay - Product Status
nCounter Dx LymphMark Assay - Product Description
nCounter FLEX Analysis System - Idiopathic Pulmonary Fibrosis Test - Product Status
nCounter FLEX Analysis System - Idiopathic Pulmonary Fibrosis Test - Product Description
Percepta Atlas - Product Status
Percepta Atlas - Product Description
Percepta Nasal Swab Test - Product Status
Percepta Nasal Swab Test - Product Description
Percepta Nasal Swab Test - Clinical Utility of Management of Patients With CT and LDCT Identified Pulmonary Nodules Using the Percepta Nasal Swab Classifier
Prosigna NGS Test - Product Status
Prosigna NGS Test - Product Description
Veracyte Inc, Key Employees
Veracyte Inc, Subsidiaries
Glossary
List of Figures
Veracyte Inc Pipeline Products by Equipment Type
Veracyte Inc Pipeline Products by Development Stage
Veracyte Inc Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings